LSV Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $501M | Sell |
|
|||||
|
2025
Q1 | $551M | Sell |
|
|||||
|
2024
Q4 | $464M | Sell |
|
|||||
|
2024
Q3 | $443M | Sell |
|
|||||
|
2024
Q2 | $378M | Sell |
|
|||||
|
2024
Q1 | $416M | Sell |
|
|||||
|
2023
Q4 | $480M | Sell |
|
|||||
|
2023
Q3 | $460M | Sell |
|
|||||
|
2023
Q2 | $485M | Sell |
|
|||||
|
2023
Q1 | $538M | Sell |
|
|||||
|
2022
Q4 | $564M | Sell |
|
|||||
|
2022
Q3 | $412M | Buy |
|
|||||
|
2022
Q2 | $405M | Buy |
|
|||||
|
2022
Q1 | $330M | Buy |
|
|||||
|
2021
Q4 | $371M | Buy |
|
|||||
|
2021
Q3 | $303M | Buy |
|
|||||
|
2021
Q2 | $287M | Sell |
|
|||||
|
2021
Q1 | $271M | Sell |
|
|||||
|
2020
Q4 | $256M | Sell |
|
|||||
|
2020
Q3 | $290M | Buy |
|
|||||
|
2020
Q2 | $347M | Buy |
|
|||||
|
2020
Q1 | $336M | Sell |
|
|||||
|
2019
Q4 | $298M | Buy |
|
|||||
|
2019
Q3 | $287M | Sell |
|
|||||
|
2019
Q2 | $315M | Sell |
|
|||||
|
2019
Q1 | $305M | Buy |
|
|||||
|
2018
Q4 | $291M | Sell |
|
|||||
|
2018
Q3 | $364M | Buy |
|
|||||
|
2018
Q2 | $334M | Buy |
|
|||||
|
2018
Q1 | $352M | Buy |
|
|||||
|
2017
Q4 | $327M | Buy |
|
|||||
|
2017
Q3 | $296M | Buy |
|
|||||
|
2017
Q2 | $160M | Buy |
|
|||||
|
2017
Q1 | $152M | Buy |
|
|||||
|
2016
Q4 | $157M | Buy |
|
|||||
|
2016
Q3 | $160M | Buy |
|
|||||
|
2016
Q2 | $166M | Buy |
|
|||||
|
2016
Q1 | $167M | Buy |
|
|||||
|
2015
Q4 | $175M | Buy |
|
|||||
|
2015
Q3 | $163M | Buy |
|
|||||
|
2015
Q2 | $131M | Buy |
|
|||||
|
2015
Q1 | $40.5M | Buy |
|
|||||
|
2014
Q4 | $37.6M | Buy |
|
|||||
|
2014
Q3 | $36.5M | Buy |
|
|||||
|
2014
Q2 | $12.6M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $263K | Buy |
|